Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Blood-Brain Barrier Penetration and CNS Distribution Achieving sufficient CNS concentrations is a critical pharmacokinetic requirement for a procognitive compound, and Dihexa's peptidomimetic design addresses this challenge
A phase I safety study in healthy adults confirmed that subcutaneous MOTS-c injections at doses up to 10 mg produced no serious adverse events, with a pharmacokinetic profile supporting once-daily or every-other-day dosing [3]
inject slowly and steadily [10]
This makes it an indispensable component for any laboratory or research setting
Tirzepatide or Retatrutide, an alternative, NOT a combination Tirzepatide and Retatrutide are competing multi-receptor molecules
Prescription medication only available if prescribed after an online consultation with a healthcare provider
